Filter posts

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

BIO 2014’s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move …

JOBS Act Deconstructed: Confidential Filing

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Testing-the-Waters

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Regulatory Relief

More than 40 biotech companies have gone public using provisions made available to emerging growth …

Ag Biotech: Going on the Offense

On Wednesday at the BIO International Convention a panel called “Going on the Offense: Proactive …

"When Genetic Engineering Came Of Age"

October 29 was the 30th anniversary of the approval by the Food and Drug Administration …

Playing Politics: Political Pitfalls for Animal Biotechnology

This year’s BIO Livestock Biotech Summit featured a session called Political Pitfalls for Animal Biotechnology. …

How to Become a Global Biotech Leader: Innovation and the Worldview Report

What are the BRICS of the future? Latin America, Korea, North Africa, Thailand, Turkey? Scientific …

Americans, Biotech Execs, Convention Attendees Optimistic About Biotech

What does the future hold for biotechnology? After surveying American voters, biotech executives, and attendees …

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is …